Sittings · Document

MOTION FOR A RESOLUTION (2026/2586(RSP)) 2026-02-09

On World Cancer Day

on behalf of the PPE Group · Rapporteur: Bartosz Arłukowicz, Tomislav Sokol, Dolors Montserrat, Adam Jarubas, Magdalena Adamowicz, Borys Budka, Andrzej Buła, Dariusz Joński, Andrzej Halicki, Ewa Kopacz, Elżbieta Katarzyna Łukacijewska, Jagna MarczułajtisWalczak, Letizia Moratti, DanŞtefan Motreanu, Elena Nevado del Campo, Oliver Schenk, Bartłomiej Sienkiewicz, Liesbet Sommen, Bogdan Andrzej Zdrojewski

✦ In short · AI summary of this text, generated 4 Sept 2026

This resolution marks World Cancer Day and calls for renewed commitment to Europe's Beating Cancer Plan, dedicated EU health funding, and action on cancer prevention, care, and research. It stresses integrating gender differences, supporting paediatric and geriatric oncology, improving cross-border access, ensuring affordable medicines, and protecting cancer survivors from financial discrimination.

Key points

  1. Calls on the Commission and Member States to fully implement Europe's Beating Cancer Plan through 2028-2034, with annual reporting and transparency.
  2. Regrets lack of dedicated health budget in 2028-2034 MFF; calls for dedicated EU health framework with envelope for flagship initiatives.
  3. Calls for health and oncology care to be social investment objectives via national recovery plans, including cancer infrastructure.
  4. Stresses integrating gender differences into cancer research, prevention, screening, diagnosis, and treatment.
  5. Calls for strengthened EU cooperation on paediatric oncology, including research, data sharing, clinical trials, and cross-border referrals.
  6. Calls for promotion of geriatric oncology with special consideration and funding.
  7. Calls for high-quality treatment infrastructure based on EU guidelines and scientific evidence.
  8. Calls for stronger mechanisms for cross-border access to specialised cancer care and clinical trials, especially for rare cancers.
  9. Calls for fair, timely, affordable access to oncological medicines; voluntary joint procurement, price transparency, and addressing delays.
  10. Calls on Commission to support Member States in achieving Council Recommendations on cancer screening and vaccine-preventable cancers.
  11. Calls for alignment between Beating Cancer Plan and future EU disease actions, including rare diseases.
  12. Calls for tackling health disinformation and misinformation, and for protecting cancer survivors from financial discrimination via right to be forgotten.

Who is affected

  • Cancer patients, survivors, families, healthcare workers, and researchers across Europe.
  • Children, adolescents, and young adults with cancer and their families.
  • Elderly patients with cancer.
  • Cancer survivors seeking financial services like mortgages, loans, and insurance.

Figures and deadlines

  • 2.7 million people diagnosed with cancer annually in the EU; 1.3 million die.
  • Cancer health spending doubled from EUR 54 billion to EUR 120 billion in 2023, reaching 6.9% of total health expenditure.
  • By 2050, per-capita cancer spending expected to be 59% higher in real terms in EU-27.
  • At least 40% of cancer cases could be prevented with effective primary prevention.
  • 2.3 million women die prematurely from cancer each year; 1.5 million preventable, 800,000 avertable with optimal care.

Legal basis: Article 168 of the Treaty on the Functioning of the European Union

Written by a language model from the full text only; every figure comes from the text and ¶ links to the paragraph it rests on. Check the text itself before relying on it.